期刊文献+

去甲长春花碱加顺铂方案治疗晚期非小细胞肺癌的临床观察 被引量:1

原文传递
导出
摘要 目的评估去甲长春花碱 (NVB)与顺铂 (DDP)联合的NP方案在治疗晚期非小细胞肺癌 (NSCLC)的疗效与毒性反应。方法 34例NSCLC患者采用NP方案治疗 ,其治疗剂量 :NVB 2 5~ 30mg/m2 ,静注第 1、8天 ;DDP 75~ 10 0mg/m2 /周期 ,静滴第 1、2、3天 (配合水化 ) ,2 1天为 1个周期 ,至少化疗 2个周期。结果 34例患者中无一例CR ,16例PR ,有效率 4 7.0 % (16 / 34) ,13例稳定 ,5例进展。 1年生存率 39% ,中位疾病进展时间 (TTP) 5 .8个月 ,中位生存时间 9.2个月 ,主要毒性为骨髓抑制和消化道反应 ,34例患者中 ,白细胞下降 30例 (88% ) ,其中Ⅲ、Ⅳ度为 14例 (4 1% ) ,以恶心、呕吐反应突出者 31例 (91.2 % ) ,无一例Ⅳ度消化道反应。结论NP方案对NSCLC有较高的有效率和较长的生存期和缓解期。可推荐为一线治疗方案。
作者 周孟强 朱辉
机构地区 河南省肿瘤医院
出处 《中国综合临床》 北大核心 2003年第6期532-533,共2页 Clinical Medicine of China
  • 相关文献

参考文献6

二级参考文献8

  • 1Sandler A. First-line combination chemotherapy for advanced non -small cell lung cancer: the Eastern Cooperative Oncology Group and Southwest Oncology Group experience. Semin Oncol, 1999,26(5 Suppl 15):44~51.
  • 2Johnson SA, Harper P, Hortobagyi GN, et al. Vinorelbine: an overview. Cancer Treat Rev ,1996.22(3) :127~142.
  • 3Sorensen JB. Vinorelbine a review of its antitumor activity in lung cancer. Drugs, 1992,44(suppl) :60~65.
  • 4Le Chevalier T,Brisgand D, Douillard J Y,et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol,1994,12(2) :360~367.
  • 5Potier P. Hiistory of the discovery of navelbine. In: Pierre Fabre Oncologic eds. Navelbine:update and new trends. 1 st ed. Francce:John Libbry Eurotext ltd, 1991.4.
  • 6管忠震,癌症,1993年,12卷,217页
  • 7张湘茹,北京医学,1992年,14卷,171页
  • 8张湘茹,孙燕.新抗肿瘤药异长春花碱[J].北京医学,1992,14(3):171-176. 被引量:147

共引文献534

同被引文献6

  • 1Wildfang 1 ,Tschechne B, Raack B ,et al. Neoadjuvant chemotherapy with earboplatin/paclitaxel in locally advanced resectable non small cell lung cancer ( NSCLC ) [C]. Interactive Cardiovascular and Thoracic Surgery,2003. 167-176.
  • 2Fabrice B, Christophe D, Bruno C, et al. Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage ⅢA-N2 non-small cell lung cancer [ J ]. Elsevier Science,2003,7(3) :103-115.
  • 3Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone inpatients with non-small-call lung cancer[ J]. N Engl J Meal, 1994,330(2) :153-158.
  • 4Both JA,Fossella F,Komaki R,et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage ⅢA non-small-cell lung cancer[ J]. J Natl Cancer Inst,1994,86(9) :673-680.
  • 5Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis[J]. Ann Thorac Surg,1992,53(6) :992-998.
  • 6Yoneda S,Hibino S,Gotoh 1,et al. A comparative trial on induction chemotherapy followed by surgery (CRS) or immediate surgery(IS) for stage Ⅲ NSCLC[J]. Proc Am Soc Clin,1995,14(8) :1128.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部